{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:31:43Z","timestamp":1790087503968,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.kint.2018.09.018","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T05:10:32Z","timestamp":1547788232000},"page":"412-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A distinct bone phenotype in ADPKD patients with end-stage renal disease"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2846-2026","authenticated-orcid":false,"given":"Bjorn","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Behets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9981","key":"10.1016\/j.kint.2018.09.018_bib1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"issue":"9569","key":"10.1016\/j.kint.2018.09.018_bib2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.09.018_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000421651","article-title":"Genetic heterogeneity of polycystic kidney disease in Europe","volume":"97","author":"Peters","year":"1992","journal-title":"Contrib Nephrol"},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0695-151","article-title":"The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains","volume":"10","author":"Hughes","year":"1995","journal-title":"Nat Genet"},{"issue":"5266","key":"10.1016\/j.kint.2018.09.018_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bone.2012.11.016","article-title":"Emerging role of primary cilia as mechanosensors in osteocytes","volume":"54","author":"Nguyen","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.kint.2018.09.018_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/nyas.12463","article-title":"Function and regulation of primary cilia and intraflagellar transport proteins in the skeleton","volume":"1335","author":"Yuan","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.kint.2018.09.018_bib8","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","article-title":"The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia","volume":"13","author":"Yoder","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.09.018_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1749-6632.2009.05243.x","article-title":"Osteocyte primary cilium and its role in bone mechanotransduction","volume":"1192","author":"Temiyasathit","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11154-015-9313-4","article-title":"Physiological mechanisms and therapeutic potential of bone mechanosensing","volume":"16","author":"Xiao","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"10.1016\/j.kint.2018.09.018_bib11","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1096\/fj.10-180299","article-title":"Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice","volume":"25","author":"Xiao","year":"2011","journal-title":"FASEB J"},{"issue":"41","key":"10.1016\/j.kint.2018.09.018_bib12","doi-asserted-by":"crossref","first-page":"30884","DOI":"10.1074\/jbc.M604772200","article-title":"Cilia-like structures and polycystin-1 in osteoblasts\/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression","volume":"281","author":"Xiao","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2018.09.018_bib13","unstructured":"Gitomer BY, Pereira RC, Malaczewski MR, et\u00a0al. Identification of a bone defect in ADPKD. Oral abstract presented at Kidney Week of the American Nephrology Society, November 11\u201316, 2014; Philadelphia, PA."},{"key":"10.1016\/j.kint.2018.09.018_bib14","unstructured":"Gitomer BY, Stoneback JW, Pereira RC, et\u00a0al. Bone mineral density is reduced in patients with autosomal dominant polycystic kidney disease. Poster abstract presented at Kidney Week of the American Nephrology Society, November 15\u201320, 2016; Chicago, IL."},{"issue":"5944","key":"10.1016\/j.kint.2018.09.018_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.4.5944.557","article-title":"Effects of age, sex, and polycystic disease on progressive bone disease of renal failure","volume":"4","author":"Moorhead","year":"1974","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.kint.2018.09.018_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.semnephrol.2014.09.004","article-title":"When, how, and why a bone biopsy should be performed in patients with chronic kidney disease","volume":"34","author":"Torres","year":"2014","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1016\/j.kint.2018.09.018_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00223-013-9778-7","article-title":"(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease","volume":"93","author":"Frost","year":"2013","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"10.1016\/j.kint.2018.09.018_bib18","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1210\/jc.2017-01157","article-title":"Evidence for bone and mineral metabolism alterations in children with autosomal dominant polycystic kidney disease","volume":"102","author":"De Rechter","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.kint.2018.09.018_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ekir.2017.01.001","article-title":"Sclerostin horizontal line A debutant on the autosomal dominant polycystic kidney disease scene?","volume":"2","author":"Jankowska","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2018.09.018_bib20","unstructured":"Gitomer BY, Wolf MS, Salusky IB, et\u00a0al. Low serum levels of alkaline phosphatase are associated with greater total kidney volume in patients with early autosomal dominant polycystic kidney disease. Poster abstract presented at Kidney Week of the American Nephrology Society, November 15\u201320, 2016; Chicago, IL."},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"issue":"27","key":"10.1016\/j.kint.2018.09.018_bib22","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","article-title":"The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in\u00a0vitro","volume":"290","author":"Spatz","year":"2015","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.kint.2018.09.018_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ncb1670","article-title":"Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms","volume":"10","author":"Corbit","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.kint.2018.09.018_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000488115","article-title":"Levels of endocan, angiopoietin-2, and hypoxia-inducible factor-1a in patients with autosomal dominant polycystic kidney disease and different levels of renal function","volume":"47","author":"Raptis","year":"2018","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.kint.2018.09.018_bib25","doi-asserted-by":"crossref","first-page":"e65940","DOI":"10.1371\/journal.pone.0065940","article-title":"HIF-1alpha inhibits Wnt signaling pathway by activating Sost expression in osteoblasts","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.kint.2018.09.018_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ndt\/gfu301","article-title":"High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study","volume":"30","author":"Drechsler","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.kint.2018.09.018_bib28","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","article-title":"Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?","volume":"28","author":"Viaene","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"15","key":"10.1016\/j.kint.2018.09.018_bib29","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.kint.2018.09.018_bib30","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s00198-012-2228-y","article-title":"Bone mineralization: from tissue to crystal in normal and pathological contexts","volume":"24","author":"Bala","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.kint.2018.09.018_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/TP.0000000000000808","article-title":"Fracture incidence in adult kidney transplant recipients","volume":"100","author":"Naylor","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.09.018_bib32","unstructured":"Gitomer BY, Dalrymple LS, You Z, et\u00a0al. Fracture rates and post-discharge outcomes among patients undergoing hemodialysis across etiologies of kidney diseases. Poster abstract presented at Kidney Week of the American Nephrology Society, October 31\u2013November 5, 2017; New Orleans, LA."},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2215\/CJN.09020911","article-title":"Soluble Klotho and autosomal dominant polycystic kidney disease","volume":"7","author":"Pavik","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.kint.2018.09.018_bib34","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/clinchem\/30.11.1731","article-title":"Two direct (nonchromatographic) assays for 25-hydroxyvitamin D","volume":"30","author":"Bouillon","year":"1984","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.kint.2018.09.018_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/clinchem\/26.5.562","article-title":"A\u00a0radioimmunoassay for 1,25-dihydroxycholecalciferol","volume":"26","author":"Bouillon","year":"1980","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/clinchem\/36.2.271","article-title":"Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies","volume":"36","author":"Bouillon","year":"1990","journal-title":"Clin Chem"},{"issue":"13\u201314","key":"10.1016\/j.kint.2018.09.018_bib37","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinbiochem.2014.04.007","article-title":"Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients","volume":"47","author":"Cavalier","year":"2014","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.kint.2018.09.018_bib38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.kint.2018.09.018_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.kint.2018.09.018_bib40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-015-3233-8","article-title":"Inflammation and the bone-vascular axis in end-stage renal disease","volume":"27","author":"Viaene","year":"2016","journal-title":"Osteoporos Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:52:04Z","timestamp":1758761524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818307713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0085253818307713"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.09.018","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A distinct bone phenotype in ADPKD patients with end-stage renal disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}